News

Hargreave Hale AIM VCT PLC Shares Buyback Update

Hargreave Hale AIM VCT PLC Shares Buyback Update

Hargreave Hale AIM VCT PLC Shares Buyback Update

Hargreave Hale AIM VCT PLC, commonly referred to as the Company, has recently taken steps to manage its share capital actively. The Company has purchased a total of 24,370 ordinary shares at a price of 33.34 pence each for the purpose of cancellation. This strategic move reflects a conscious effort to optimize shareholder value and reduce the overall number of shares in circulation.

Details of the Recent Share Purchase

This recent purchase was executed with the intention of effectively decreasing the number of shares available in the market. Following this acquisition and subsequent cancellation of the shares, a total of 371,158,339 ordinary shares of 1p each will remain issued. These shares continue to carry one vote each, demonstrating the Company's commitment to transparency and shareholder engagement.

Implications for Shareholders

With the reduced number of shares, shareholders will find that the total voting rights in the Company will now stand at 371,158,339. This adjustment is critical, as it can affect shareholder calculations regarding their interests in the Company as stipulated by the Disclosure and Transparency Rules.

The Role of JTC (UK) Limited

To facilitate these transactions and maintain clear communication with stakeholders, Hargreave Hale AIM VCT PLC collaborates closely with JTC (UK) Limited. This partnership ensures that all administrative and compliance functions are conducted smoothly, allowing the Company to focus on its primary operations while keeping shareholders well-informed.

Efficient Communication Channels

For any inquiries or additional information, interested parties can reach out to JTC (UK) Limited directly. Contact persons include Uloma Adighibe and Alexandria Tivey, available through the email HHV.CoSec@jtcgroup.com or by phone at +44 203 832 3877 and +44 203 832 3891. This open line of communication reflects a commitment to shareholder engagement and transparency.

Conclusion and Future Outlook

The recent buyback and cancellation of ordinary shares by Hargreave Hale AIM VCT PLC affirm its ongoing strategy to enhance shareholder value and maintain a robust capital structure. As the Company navigates the evolving market landscape, it remains focused on delivering sustainable growth while ensuring that shareholder rights are upheld and transparent communications are maintained. If you're interested in understanding how these actions may influence your investment, it's advisable to stay connected with the Company’s announcements and updates.

Frequently Asked Questions

What was the purpose of buying back shares?

The Company aimed to reduce the number of shares in circulation to enhance shareholder value and maintain a stable capital structure.

How many shares remain after the buyback?

After the cancellation of shares, a total of 371,158,339 ordinary shares will remain in issue.

Who can I contact for more information?

For inquiries, you can reach out to Uloma Adighibe or Alexandria Tivey at JTC (UK) Limited via email or phone.

What is the price per share for the recent buyback?

The recent buyback was executed at a price of 33.34 pence per share.

How does this affect my voting rights?

The total voting rights will now be 371,158,339, reflecting the shares currently in issue after the cancellation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 50

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 36

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 67

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 46

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 95

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 109

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 73

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading

Top 5 Most Recently Viewed Articles

LandingAI's Significant Achievement at Snowflake Conference

Updated Category News Views 140

LandingAI Recognized as Partner of the Year LandingAI has received notable recognition at the Snowflake annual user conference for its exceptional contributions to the data cloud landscape. This acknowledgement highlights how LandingAI not only stands out in the tech industry but also pushes the boundaries of what's possible with artificial intelligence and data...

Continue Reading
Aventura Mall Tops USA Shopping Malls Again in 2026

Updated Category News Views 22

A Second Victory for Aventura Mall Well, folks, here we are again; Aventura Mall has pulled it off for a second consecutive year, grabbing the coveted 'Best Mall in the United States' title from the esteemed USA Today 10Best Readers’ Choice Awards. Now, before you roll your eyes, let's acknowledge that this ain't just a shiny plaque on the wall; it's a testament to how...

Continue Reading
Critical Metals Corp Reveals $3 Billion Valuation for Tanbreez Project

Updated Category News Views 500

Insights into Critical Metals Corp’s Tanbreez Project Critical Metals Corp (NASDAQ: CRML) recently announced an independent Preliminary Economic Assessment (PEA) for its renowned Tanbreez Project, located in Southern Greenland. This project stands out as one of the world's largest rare earth deposits, boasting a significant mineral resource of 4.7 billion metric tons of...

Continue Reading
Salesforce's Promising Future: What Investors Need to Know

Updated Category News Views 100

Salesforce's Resilient Position Amid Economic Shifts As investors navigate the current economic landscape, many are focused intently on immediate data rather than the implications for the future. With an election looming and a new earnings season underway, there's much to consider. The timeout on interest rate deliberations further complicates the financial scene, as the...

Continue Reading
Exciting Announcements for Garden Centres Canada Summit 2025

Updated Category News Views 131

Garden Centres Canada Summit 2025: An Overview The Canadian Nursery Landscape Association (CNLA) is excited to announce the upcoming Garden Centres Canada Summit 2025. This highly anticipated event will take place in Winnipeg, uniting garden centre operators, retail professionals, and industry leaders. Event Details and Schedule The Garden Centres Canada Summit is a...

Continue Reading